<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Press Release | Tissuepathology.com</title>
	<atom:link href="https://tissuepathology.com/category/digital-pathology-news/press-release/feed/" rel="self" type="application/rss+xml" />
	<link>https://tissuepathology.com</link>
	<description>Educational and informative</description>
	<lastBuildDate>Mon, 14 Sep 2026 13:14:43 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://tissuepathology.com/wp-content/uploads/2017/07/cropped-Portrait_640x960px-32x32.png</url>
	<title>Press Release | Tissuepathology.com</title>
	<link>https://tissuepathology.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Proscia: Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine</title>
		<link>https://tissuepathology.com/2026/09/14/proscia-unilabs-advances-digital-pathology-across-europe-with-proscia-shaping-the-future-of-precision-medicine/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Mon, 14 Sep 2026 13:14:43 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[Proscia]]></category>
		<category><![CDATA[Unilabs]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24674</guid>

					<description><![CDATA[<p>‍Philadelphia — September 14, 2026 — Proscia® today announced that Unilabs, one of the leading providers of medical diagnostic services in Europe, is leveraging the Concentriq® platform to support the advancement of digital pathology across its network. Multiple Unilabs countries are already using Concentriq AP-Dx* for routine case review, with others expected to deploy it before the end of [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/14/proscia-unilabs-advances-digital-pathology-across-europe-with-proscia-shaping-the-future-of-precision-medicine/">Proscia: Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Aiforia honors three AI pioneers in digital pathology at the 38th European Congress of Pathology</title>
		<link>https://tissuepathology.com/2026/09/11/aiforia-honors-three-ai-pioneers-in-digital-pathology-at-the-38th-european-congress-of-pathology/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 11 Sep 2026 13:01:26 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Clinical Laboratories]]></category>
		<category><![CDATA[Conferences]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[38th European Congress of Pathology]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AI Navigator award]]></category>
		<category><![CDATA[Aiforia]]></category>
		<category><![CDATA[Albino Eccher]]></category>
		<category><![CDATA[Anne Vincent-Salomon]]></category>
		<category><![CDATA[Antonin Bouroumeau]]></category>
		<category><![CDATA[clinical diagnostics]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24671</guid>

					<description><![CDATA[<p>Aiforia hands out AI Navigator awards to recognize three individuals for their exceptional contributions to advancing AI in routine diagnostics. Aiforia Technologies awards three AI pioneers, Anne Vincent-Salomon, Albino Eccher, and Antonin Bouroumeau, for their exceptional contributions to advancing AI in clinical diagnostics. The AI Navigator award ceremony is taking place at the 38th European Congress of Digital Pathology, [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/11/aiforia-honors-three-ai-pioneers-in-digital-pathology-at-the-38th-european-congress-of-pathology/">Aiforia honors three AI pioneers in digital pathology at the 38th European Congress of Pathology</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom</title>
		<link>https://tissuepathology.com/2026/09/09/source-bioscience-selects-indica-labs-halo-ap-as-the-digital-pathology-platform-powering-the-future-of-nhs-outsourcing-in-the-united-kingdom/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Wed, 09 Sep 2026 13:23:24 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[HALO AP™]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Indica Labs]]></category>
		<category><![CDATA[NHS Outsourcing]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Source BioScience]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24665</guid>

					<description><![CDATA[<p>Albuquerque, NM, and Nottingham, September 8, 2026 – Indica Labs, the trusted global leader in AI-powered digital pathology and Source Bioscience, the United Kingdom’s leading provider of histopathology services, today announced Source Bioscience’s successful expansion of its digital pathology operation powered by HALO AP®. Since going live at Nottingham headquarters in October 2025, the organization has [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/09/source-bioscience-selects-indica-labs-halo-ap-as-the-digital-pathology-platform-powering-the-future-of-nhs-outsourcing-in-the-united-kingdom/">Source BioScience Selects Indica Labs’ HALO AP® as the Digital Pathology Platform Powering the Future of NHS Outsourcing in the United Kingdom</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026</title>
		<link>https://tissuepathology.com/2026/09/08/lunit-unveils-new-ai-powered-tumor-microenvironment-insights-in-lung-cancer-at-wclc-2026/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Tue, 08 Sep 2026 12:10:37 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Conferences]]></category>
		<category><![CDATA[Digital Pathology Conferences]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Education]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[International]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[2026 World Conference on Lung Cancer]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Lung Cancer]]></category>
		<category><![CDATA[Lunit]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Tumors Microenvironment]]></category>
		<category><![CDATA[WCLC 2026]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24663</guid>

					<description><![CDATA[<p>SEOUL, SOUTH KOREA, September 8, 2026 — Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced the presentation of three studies at the 2026 World Conference on Lung Cancer (WCLC 2026), to be held in Seoul, South Korea, from September 12 to 15. Across the three studies, Lunit researchers and [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/08/lunit-unveils-new-ai-powered-tumor-microenvironment-insights-in-lung-cancer-at-wclc-2026/">Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows</title>
		<link>https://tissuepathology.com/2026/09/04/hamamatsu-and-aixmed-announce-collaboration-to-evaluate-scanpilot-integration-in-cytology-research-workflows/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Fri, 04 Sep 2026 11:32:15 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Health Technology Collaboration]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[AIxMed]]></category>
		<category><![CDATA[Collaboration]]></category>
		<category><![CDATA[cytology]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[hamamatsu]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Research]]></category>
		<category><![CDATA[ScanPilot]]></category>
		<category><![CDATA[Workflows]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24658</guid>

					<description><![CDATA[<p>Hamamatsu and AIxMed: The collaboration will allow interoperability between ScanPilot™ and NanoZoomer® scanners for technical image-quality assessment and autonomous rescanning in cytology. BRIDGEWATER, N.J., Sept. 3, 2026 /PRNewswire/ &#8212; Hamamatsu Corporation and AIxMed, a developer of software for digital cytology workflows, today announced a technical collaboration to evaluate the integration of AIxMed&#8217;s ScanPilot™ with selected Hamamatsu NanoZoomer® whole-slide scanner [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/04/hamamatsu-and-aixmed-announce-collaboration-to-evaluate-scanpilot-integration-in-cytology-research-workflows/">Hamamatsu and AIxMed Announce Collaboration to Evaluate ScanPilot Integration in Cytology Research Workflows</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
		<item>
		<title>Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems</title>
		<link>https://tissuepathology.com/2026/09/03/hamamatsu-receives-fda-510k-clearance-for-nanozoomer-s20md-and-s540md-slide-scanner-systems/</link>
		
		<dc:creator><![CDATA[Erica Goodpaster]]></dc:creator>
		<pubDate>Thu, 03 Sep 2026 12:53:02 +0000</pubDate>
				<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Digital Pathology News]]></category>
		<category><![CDATA[Image Analysis]]></category>
		<category><![CDATA[Pathology News]]></category>
		<category><![CDATA[Press Release]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[digital pathology]]></category>
		<category><![CDATA[FDA 510(k) Clearance]]></category>
		<category><![CDATA[hamamatsu]]></category>
		<category><![CDATA[image analysis]]></category>
		<category><![CDATA[NanoZoomer®]]></category>
		<category><![CDATA[Pathology]]></category>
		<category><![CDATA[Slide scanner systems]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<guid isPermaLink="false">https://tissuepathology.com/?p=24656</guid>

					<description><![CDATA[<p>Hamamatsu: New FDA clearances expand Hamamatsu&#8217;s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions. HAMAMATSU, Japan, Sept. 2, 2026 /PRNewswire/ &#8212; Hamamatsu Photonics K.K. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD Slide scanner systems. Building on the previously [&#8230;]</p>
The post <a href="https://tissuepathology.com/2026/09/03/hamamatsu-receives-fda-510k-clearance-for-nanozoomer-s20md-and-s540md-slide-scanner-systems/">Hamamatsu Receives FDA 510(k) Clearance for NanoZoomer S20MD and S540MD Slide scanner systems</a> first appeared on <a href="https://tissuepathology.com">Tissuepathology.com</a>.]]></description>
		
		
		
			</item>
	</channel>
</rss>
